» Articles » PMID: 36789140

Neurological Complications and Effects of COVID-19: Symptoms and Conceivable Mechanisms

Overview
Date 2023 Feb 15
PMID 36789140
Authors
Affiliations
Soon will be listed here.
Abstract

A novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in December 2019 in Wuhan, China. The new coronavirus disease (COVID-19) was declared a global pandemic by the World Health Organization (WHO) in March 2020. SARS-CoV-2 can invade the nervous system aside from infecting the respiratory system as its primary target. The most common nervous system symptoms of COVID-19 are stated as headache, myalgia, fatigue, nausea, vomiting, sudden and unexplained anosmia, and ageusia. More severe conditions such as encephalomyelitis, acute myelitis, thromboembolic events, ischemic stroke, intracerebral hemorrhage, Guillain-Barré-syndrome, Bell's palsy, rhabdomyolysis, and even coma have also been reported. Cohort studies revealed that neurological findings are associated with higher morbidity and mortality. The neurological symptoms and manifestations caused by SARS-CoV-2 and COVID-19 are examined and summarized in this article.

Citing Articles

SARS-CoV-2: A synergy to the Alzheimer's disease.

Shaik K, Kumar D, Srikanth P, Nandi S J Neurovirol. 2025; .

PMID: 39998800 DOI: 10.1007/s13365-025-01247-w.


Plasmapheresis in post-COVID-19 myelitis: A case report.

Mitarnun W, Kongngern L, Tantisungvarakoon P, Boonsayomphu T, Tianchetsada N, Potchanapong T Qatar Med J. 2024; 2024(1):19.

PMID: 38654819 PMC: 11037093. DOI: 10.5339/qmj.2024.19.


COVID-19 and Alzheimer's disease: Impact of lockdown and other restrictive measures during the COVID-19 pandemic.

Nawaz A, Haider M, Akhtar S Biomol Biomed. 2023; 24(2):219-229.

PMID: 38078809 PMC: 10950341. DOI: 10.17305/bb.2023.9680.

References
1.
Wei C, Liu Y, Liu Y, Zhang K, Su D, Zhong M . Clinical characteristics and manifestations in older patients with COVID-19. BMC Geriatr. 2020; 20(1):395. PMC: 7542569. DOI: 10.1186/s12877-020-01811-5. View

2.
Zhao X, Xu X, Yin H, Hu Q, Xiong T, Tang Y . Clinical characteristics of patients with 2019 coronavirus disease in a non-Wuhan area of Hubei Province, China: a retrospective study. BMC Infect Dis. 2020; 20(1):311. PMC: 7188494. DOI: 10.1186/s12879-020-05010-w. View

3.
Ferguson J, Rosser J, Quintero O, Scott J, Subramanian A, Gumma M . Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020. Emerg Infect Dis. 2020; 26(8):1679-1685. PMC: 7392471. DOI: 10.3201/eid2608.201776. View

4.
Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, Oreni L . Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clin Infect Dis. 2020; 71(15):889-890. PMC: 7184514. DOI: 10.1093/cid/ciaa330. View

5.
Wang W, Xin C, Xiong Z, Yan X, Cai Y, Zhou K . Clinical Characteristics and Outcomes of 421 Patients With Coronavirus Disease 2019 Treated in a Mobile Cabin Hospital. Chest. 2020; 158(3):939-946. PMC: 7207119. DOI: 10.1016/j.chest.2020.05.515. View